Endotracheal Tube Market is Estimated To Witness High Growth Owing To Trends In Innovation in Design and Features
The Endotracheal Tube Market is estimated to be valued at US$ 920.0 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The endotracheal tube market involves medical devices that are inserted through the mouth or nose into the trachea (windpipe) to maintain an open airway and/or to administer certain drugs. Endotracheal tubes are commonly used during surgery, during an emergency like cardiac arrest, and with patients who need assistance with breathing. They provide a clear passageway to deliver oxygen or other gases to the lungs and allow access for suctioning secretions from below the vocal cords.
Market key trends:
Innovation in the design and features of endotracheal tubes is one of the major trends being observed in the market. Players are focusing on developing endotracheal tubes with various coatings and materials to reduce complications. For instance, endotracheal tubes coated with antiseptics and antibiotics are being developed to prevent ventilator-associated pneumonia. Similarly, endotracheal tubes with magnetic and ultrasound-detectable components are being introduced to allow for accurate placement verification. Such innovations are expected to drive the demand for endotracheal tubes during the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as endotracheal tubes are required equipments in critical care settings and need high investments for manufacturing facilities. However, the presence of established players pose barrier for new players.
Bargaining power of buyers: The bargaining power of buyers is moderate as endotracheal tubes have limited substitutes and buyers cannot switch easily. However, the availability of generics exert pressure on price.
Bargaining power of suppliers: The bargaining power of suppliers is low as raw materials required for endotracheal tubes manufacturing are easily available.
Threat of new substitutes: The threat of new substitutes is low as endotracheal intubation remains the standard of care for airway management of critically ill patients.
Competitive rivalry: High due to presence of global established players.
SWOT Analysis
Strength: Availability of wide portfolio of products with innovative features for safety and comfort. Strong brand image and distribution network of key players.
Weakness: Endotracheal tubes procedure is invasive in nature and requires skilled professionals. High costs associated with advanced endotracheal tubes.
Opportunity: Increasing ICU admissions and number of surgical procedures offer significant growth opportunities. Emerging markets with growing healthcare expenditure present untapped potential.
Threats: Stringent regulatory framework. Risk of endotracheal intubation procedures.
Key Takeaways
The Global Endotracheal Tube Market Size is expected to witness high growth, exhibiting CAGR of 6.6% over the forecast period, due to increasing ICU admissions, rising prevalence of respiratory diseases, and growing geriatric population needing critical care.
Regional analysis Asia Pacific region is expected to witness fastest growth in the Endotracheal Tube Market owing to rising healthcare expenditure, growing incidences of chronic diseases, and improving access to healthcare in developing countries such as India and China. North America dominated the global endotracheal tube market in 2023 and is expected to continue its dominance during the forecast period due to presence of established healthcare infrastructure and advanced healthcare facilities in the region.
Key players operating in the Endotracheal Tube market are Medtronic Plc, Teleflex Inc., ConvaTec Inc., Smiths Medical, Neurovision Medical Products, Intersurgical Inc., Royax, Novo Klinik-Service GmbH, Avanos Medical, Inc., Bactiguard, and N8 Medical LLC. Key players are focusing on new product launches and partnerships to strengthen their market position. For instance, in 2022, Teleflex launched Airway Pro Gum Elastic Bougie- Assisted Intubation for Improved Airway Management.